Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
Chimeric antigen receptor (CAR) T cells represent one of the newest frontiers of cell therapy. Their application currently involves relapsed/refractory aggressive B cell lymphoma and leukemia as a standard of care, while several studies are exploring CAR-T to treat multiple myeloma and other hematol...
Saved in:
Main Authors: | Eugenio Galli, Silvia Bellesi, Marcello Viscovo, Federica Sorà, Stefan Hohaus, Nicola Piccirillo, Luca Laurenti, Patrizia Chiusolo, Valerio De Stefano, Simona Sica, Gina Zini |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2021-10-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | http://mjhid.org/index.php/mjhid/article/view/4745 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
by: Eugenio Galli, et al.
Published: (2024-02-01) -
Cytomorphological and Cytomorphometric Analysis of Oral Squames in Smokers Using Computer Aided Image Analysis System
by: Priyanka Choudhary, et al.
Published: (2024-12-01) -
New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies
by: Yuanyuan Yang, et al.
Published: (2024-11-01) -
Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects
by: Mehdi Alidadi, et al.
Published: (2024-11-01) -
Soluble factors released by peripheral blood-derived CAR-NK cells cause bystander myeloid cell activation
by: Supreet Khanal, et al.
Published: (2024-12-01)